Wall Street PR

Company

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024

Date:

Unicycive Therapeutics (NASDAQ:UNCY) just reported results for the first quarter of 2024.

  • Unicycive Therapeutics reported earnings per share of -61 cents. This was below the analyst estimate for EPS of -15 cents.
  • The company reported revenue of $675,000.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Go Source

Chart

SignUp For Breaking Alerts

New Graphic

We respect your email privacy

Share post:

Popular

More like this
Related

Retail Sales Post a 22-Month Low: Feb. 14, 2025

Interest rates are plunging from both relief that Trump...

What’s Eating at the Consumer?

Your Privacy When you visit any website it may use...

Taiwan’s TSMC Commits $65B to U.S. Factories Amid Trump’s Tariff Threat

Taiwan plans to strengthen its ties with the U.S....

Tariffs, tech earnings, and inflation concerns test markets

Key takeaways Tariff news US tariffs against Canadian and Mexican goods...